webinar
Oct. 27-28, 2025, Boston, MA, USA - Booth 114.
Read More

(4S)-4-Azido-L-proline

  CAS No.: 892128-58-4   Cat No.: BADC-01984   Purity: ≥99% by HPLC 4.5  

(4S)-4-Azido-L-proline is a derivative of L-proline with an azide (N3) group on the 4-position of the proline ring. It is used in peptide synthesis and bioconjugation for introducing azide-functionalized residues that can participate in click chemistry reactions, enabling site-specific modifications and functionalization.

(4S)-4-Azido-L-proline

Structure of 892128-58-4

Quality
Assurance

Worldwide
Delivery

24/7 Customer
Support
Category
ADC Linker
Molecular Formula
C5H8N4O2
Molecular Weight
156.14
Storage
Store at 2-8 °C

* For research and manufacturing use only. We do not sell to patients.

Size Price Stock Quantity
-- $-- In stock

Looking for different specifications? Click to request a custom quote!

Capabilities & Facilities

Popular Publications Citing BOC Sciences Products
Synonyms
(S)-4-Azido-L-proline; H-Pro(4-N3) (2S,4S); H-L-Pro(4-N3) (2S,4S); H-L-Pro(4-N3)-OH (2S,4S); H-Pro(4-N3)-OH (2S,4S); (2S,4S)-H-L-Pro(4-N3)-OH
IUPAC Name
(2S,4S)-4-azidopyrrolidine-2-carboxylic acid
Canonical SMILES
C1[C@@H](CN[C@@H]1C(=O)O)N=[N+]=[N-]
InChI
InChI=1S/C5H8N4O2/c6-9-8-3-1-4(5(10)11)7-2-3/h3-4,7H,1-2H2,(H,10,11)/t3-,4-/m0/s1
InChIKey
PPRFZPZRQYPCER-IMJSIDKUSA-N
Melting Point
147-154°C
Appearance
White or off-white crystalline powder
Storage
Store at 2-8 °C

(4S)-Azido-L-Proline hydrochloride, a versatile compound with diverse applications in biochemical and pharmaceutical research, serves as a cornerstone in various scientific fields. Here are four key applications presented with high perplexity and burstiness:

Chemical Biology: At the intersection of chemistry and biology, (4S)-Azido-L-Proline hydrochloride finds its niche as a tool for the site-specific labeling of proteins. Its azido group facilitates click chemistry reactions, allowing for precise tagging and probing of proteins. Researchers leverage this capability to delve into protein interactions and follow protein localization dynamics within cells with intricate detail.

Peptide Synthesis: In the realm of peptide synthesis, (4S)-Azido-L-Proline plays a critical role in crafting modified peptides for structural and functional analyses. By integrating this compound into peptides, scientists can introduce functional motifs for subsequent biochemical modifications, creating peptides with tailored stability, activity, or targeting characteristics. This versatility is essential for the design of peptides with specialized functionalities.

Drug Discovery: Positioned at the forefront of drug development, (4S)-Azido-L-Proline hydrochloride contributes to the creation of innovative drug candidates. Its distinctive structure is incorporated into small molecule libraries for expansive screening against diverse biological targets. This screening process aids in the identification of potential therapeutic agents with efficacy and specificity, driving forward the discovery of novel treatments.

Protein Engineering: Harnessing the power of (4S)-Azido-L-Proline hydrochloride in protein engineering opens doors to the incorporation of non-natural amino acids into proteins. This modification enables the exploration of protein folding, stability, and function, leading to the creation of proteins with novel attributes. By expanding the toolbox for synthetic biology and biotechnological applications, this application broadens the horizons of protein engineering possibilities.

1. Lurasidone: efficacy and safety in the treatment of psychotic and mood disorders
Maurizio Pompili, et al. Expert Opin Drug Saf. 2018 Feb;17(2):197-205. doi: 10.1080/14740338.2017.1379989. Epub 2017 Sep 26.
Lurasidone ([3aR,4S,7R,7aS]-2-[(1R,2R)-2-[4-(1,2-benzisothiazol-3-yl)piperazin-1yl-methyl] cyclohexylmethyl]-hexahydro-4,7-methano-2H-isoindole-1,3-dione hydrochloride; Latuda®) is a novel benzisothiazole, second-generation antipsychotic drug developed by Dainippon Sumitomo Pharma Corporation in Japan. Similar to other atypical antipsychotics it has a distinctive pharmacodynamic profile, Areas covered: This review updates reported research findings on the efficacy, safety and tolerability of LRSD for treatment of psychotic and major affective disorders, with meta-analyses. Short-term efficacy of LRSD in schizophrenia is supported by several randomized, controlled trials with daily doses of 40-160 mg, yielding relatively modest symptomatic improvements. Lurasidone has regulatory approval for treatment of undefined duration in schizophrenia. Long-term benefits and effects in schizophrenia, and both short- and long-term use for other psychotic disorders and mania have not been tested. LRSD shows unusual efficacy in acute bipolar depression even without psychotic features. However, trials of adding LRSD to lithium or valproate for bipolar disorder have yielded inconsistent findings. Expert opinion: Available research findings indicate that LRSD is effective and well-tolerated for short-term treatment of schizophrenia, and for acute bipolar depression. It has low risk of inducing weight-gain, metabolic, or cardiac abnormalities, but its risk of akathisia may exceed that of other modern antipsychotics. Needed is adequate long-term testing in schizophrenia and bipolar disorder and testing for other indications, including against alternative treatments.
2. Localised plasmonic hybridisation mode optical fibre sensing of relative humidity
LiangLiang Liu, Serhiy Korposh, David Gomez, Ricardo Correia, Barrie R Hayes-Gill, Stephen P Morgan Sens Actuators B Chem. 2022 Feb 15;353:131157. doi: 10.1016/j.snb.2021.131157.
This work reports an optical fibre probe functionalised with 'cotton-shaped' gold-silica nanostructures for relative humidity (RH) monitoring. The sensor response utilises the localised surface plasmon resonance (LSPR) of self-assembled nanostructures: gold nanospheres (40 nm) surrounded by one layer of poly (allylamine hydrochloride) and hydrophilic silica nanoparticles (10-20 nm) on the end-facet of an optical fibre via a wavelength shift of the reflected light. Sensor optimisation is investigated by varying the density of gold nanoparticles on the end-facet of an optical fibre. It is demonstrated that the plasmonic hybridisation mode appearing when the average gold interparticle distance is small (Median: 7.5 nm) is more sensitive to RH after functionalisation than the singular plasmonic mode. The plasmonic hybridisation mode sensor demonstrates a high linear regression to RH with a sensitivity of 0.63 nm/%RH and excellent reversibility. The response time (T10-90%) and recovery time (T90-10%) are calculated as 1.2 ± 0.4 s and 0.95 ± 0.18 s. The sensor shows no measurable cross-talk to temperature in the tested range between 25 °C to 40 °C and the 95% limit of agreement is 3.1%RH when compared to a commercial reference sensor. Simulation with finite element analysis reveals a polarisation-dependent plasmonic hybridisation with a redshift of plasmonic wavelength as a decrease of the interparticle distance and a higher refractive index sensitivity, which results in a high sensitivity to RH as observed in the experiment.
3. A Carbocationic Triarylmethane-Based Porous Covalent Organic Network
Sunny K S Freitas, Felipe L Oliveira, Thiago C Dos Santos, Danilo Hisse, Claudia Merlini, Célia M Ronconi, Pierre M Esteves Chemistry. 2021 Feb 1;27(7):2342-2347. doi: 10.1002/chem.202003554. Epub 2020 Dec 23.
A thermally stable carbocationic covalent organic network (CON), named RIO-70 was prepared from pararosaniline hydrochloride, an inexpensive dye, and triformylphloroglucinol in solvothermal conditions. This nanoporous organic material has shown a specific surface area of 990 m2 g-1 and pore size of 10.3 Å. The material has CO2 uptake of 2.14 mmol g-1 (0.5 bar), 2.7 mmol g-1 (1 bar), and 6.8 mmol g-1 (20 bar), the latter corresponding to 3 CO2 molecules adsorbed per pore per sheet. It is shown to be a semiconductor, with electrical conductivity (σ) of 3.17×10-7 S cm-1 , which increases to 5.26×10-4 S cm-1 upon exposure to I2 vapor. DFT calculations using periodic conditions support the findings.

The molarity calculator equation

Mass (g) = Concentration (mol/L) × Volume (L) × Molecular Weight (g/mol)

The dilution calculator equation

Concentration (start) × Volume (start) = Concentration (final) × Volume (final)

This equation is commonly abbreviated as: C1V1 = C2V2

Related Products

Contact our experts today for pricing and comprehensive details on our ADC offerings.

You May Also Be Interested In

From cytotoxin synthesis to linker design, discover our specialized services that complement your ADC projects.

ADC Linker Development Enzyme Cleavable Linker Cathepsin B Cleavable Linker Phosphatase Cleavable Linker β-Glucuronide Linker β-Galactosidase Cleavable Linker Sulfatase Cleavable Linker Chemically Cleavable Linker Non-Cleavable Linker Services Acid Cleavable Linker

Unlock Deeper ADC Insights

Learn more about payload design, linker strategies, and integrated CDMO support through our curated ADC content.

Linkers - A Crucial Factor in Antibody–Drug Conjugates In-Depth Review of ADC Linkers: Types, Mechanisms, and Research Progress New Structural Insights Solve Instability Issues of Maleimide Linkers in ADCs PEG Linkers in Antibody-Drug Conjugates Peptide Linkers in Antibody-Drug Conjugates Disulfide Linkers in Antibody-Drug Conjugates Biotinylation Reagents in Antibody-Drug Conjugates Maleimide Linkers in Antibody-Drug Conjugates Current ADC Linker Chemistry SPDB Linkers in Antibody-Drug Conjugates

Explore More ADC Products

Find exactly what your project needs from our expanded range of ADCs, offering flexible options to fit your timelines and goals.

ADC Cytotoxin

Powerful Targeted Cancer Solutions

ADC  Cytotoxin with Linker

Enhanced Stability And Efficacy

ADC Linker

Precise Conjugation For Success

Antibody-Drug  Conjugates (ADCs)

Maximized Therapeutic Performance

Auristatins

Next-Level Tubulin Inhibition

Calicheamicins

High-Impact DNA Targeting

Camptothecins

Advanced Topoisomerase Inhibition

Daunorubicins / Doxorubicins

Trusted Anthracycline Payloads

Duocarmycins

Potent DNA Alkylation Agents

Maytansinoids

Superior Microtubule Disruption

Pyrrolobenzodiazepines

Ultra-Potent DNA Crosslinkers

Traditional Cytotoxic Agents

Proven Chemotherapy Solutions

Cleavable Linker

Precise Intracellular Drug Release

Non-Cleavable Linker

Exceptional Long-Term Stability

Historical Records: SPB | Azido-PEG4-Glu-Val-Cit-PAB-MMAE | Azido-PEG4-Val-Cit-MMAE | Cyclooctyne-O-amido-PEG3-PFP ester | (2S,3R)-(Fmoc-amino)-3-azidobutyric acid | N3-L-Leu-OH | (4-Azidophenyl)acetic acid | (4S)-4-Azido-L-proline
Send Inquiry
Verification code
Inquiry Basket